Delcath Systems

1 follower


Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer.

Employees

11-50

Links


Org chart

Gerard Michel
Chief Executive Officer
Collapse
David Hoffman
General Counsel And Chief Compliance Officer
Sandra Brooks Pennell
Chief Financial Officer
Kevin Muir
Vp, General Manager Interventional Oncology
Chuck Frigon
VP of Operations
Carol Crooke, MS, RN, OCN
Assoc. Vice President Clinical Operations At Delcath Systems, Inc.
Erik van Ommen
Clinical Product Director
Martha Rook
Chief Operating Officer

Board & advisors

Roger G. Stoll
Executive Chairman
Gil Aharon
Director